Levocetirizine Oral Tablet 5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Levocetirizine: Oral tablet (5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_14775.JPG
Levocetirizine 5mg Tablet
Teva Pharmaceuticals USA
Pill Identification: 9 3  |  7701
Drug Image file DrugItem_20198.JPG
Levocetirizine 5mg Tablet
Glenmark Pharmaceuticals
Pill Identification: G G 
Drug Image file DrugItem_21056.JPG
Levocetirizine 5mg Tablet
Apotex Corp
Pill Identification: APO  |  L 5
Drug Image file DrugItem_17295.JPG
Levocetirizine 5mg Tablet
Camber Pharmaceuticals Inc
Pill Identification: H  |  161
Drug Image file default-drug-image.png
Levocetirizine 5mg Tablet

What is this Medicine?

LEVOCETIRIZINE (LEE voe se TIR i zeen) is an antihistamine. This medicine is used to treat or prevent symptoms of allergies. It is also used to help reduce itchy skin rash and hives.

Similar Brand Name Drugs : Xyzal: Oral tablet (5mg)
CVS Pharmacy Patient Statistics for Levocetirizine: Oral tablet(5mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Levocetirizine 5mg Tablet

NDC: 000937701
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Allergic Rhinitis, Chronic Idiopathic Urticaria

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Levocetirizine 5mg Tablet
Drug Image file DrugItem_14775.JPG
Teva Pharmaceuticals USA
Pill Identification: 9 3  |  7701
Shape: oval
Color: white

Reported Side Effects for Levocetirizine 5mg Tablet

Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Dyskinesia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Shortness Of Breath Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Hemolytic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Fainting Incidence:
0.2%*
Severity: MILD
Onset: EARLY
Distressed Incidence:
0.4%*
Severity: MILD
Onset: EARLY
Convulsions Incidence:
0.4-2.0%*
Severity: SEVERE
Onset: DELAYED
Weight Gain Incidence:
0.5%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
1.0-2.0%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
1.2%*
Severity: MILD
Onset: EARLY
Infection Incidence:
1.6-3.0%*
Severity: MILD
Onset: DELAYED
Nose Bleed Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Dry Mouth Incidence:
2.0-3.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
3.0-6.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
4.0-13.0%*
Severity: MILD
Onset: EARLY
Stuffy Nose Incidence:
4.0-6.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
7.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Levocetirizine

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.